TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-κB activation and IL-10 production

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 6883-6889

  Xu, Liang Guo ^a   Shu, Hong Bing ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PROTEIN TALL 1; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; MEMBRANE PROTEIN; PROTEIN; TNFRSF13C PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; YEAST; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CELL SURVIVAL; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; IMMUNOLOGY; INTRACELLULAR FLUID; METABOLISM; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL LINE; CELL SURVIVAL; DOWN-REGULATION; HUMANS; INTERLEUKIN-10; INTRACELLULAR FLUID; MEMBRANE PROTEINS; NF-KAPPA B; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037114130     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.6883     Document Type: Article

References (60)

1. Shu, H. B., W. H. Hu, and H. Johnson. 1999. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukocyte Biol. 65:680.
2. Schneider, P., F. MacKay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189:1747.
3. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis factor family and B cell stimulator. Science 285:260.
4. 2-terminal kinase. J. Biol. Chem. 274:15978.
5. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995.
6. Nardelli, B., O. Belvedere, V. Roschke, P. A. Moore, H. S. Olsen, T. S. Migone. S. Sosnovtseva, J. A. Carrell, P. Feng, J. G. Giri, and D. M. Hilbert. 2001. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198.
7. Liu, Y., L. Xu, N. Opalka, J. Kappler, H. B. Shu, and G. Zhang. 2002. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 108:383.
8. Oren, D. A., Y. Li, Y. Volovik, T. S. Morris, C. Dharia, K. Das. O. Galperina, R. Gentz, and E. Arnold. 2002. Structural basis of BLyS receptor recognition. Nat. Struct. Biol. 9:288.
9. Karpusas, M., T. G. Cachero, F. Qian, A. Boriack-Sjodin, C. Mullen, K. Strauch, Y. M. Hsu, and S. L. Kalled. 2002. Crystal structare of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J. Mol. Biol. 315:1145.
10. Shu, H. B., and H. Johnson. 2000. B cell maturation protein is a receptor for the TNF family member TALL-1. Proc. Natl. Acad. Sci. USA 97:9156.
11. Thompson, J. S., P. Schneider, S. L. Kalled, L. Wang, E. A. Lefevre, T. G. Cachero, F. MacKay, S. A. Bixler, M. Zafari, Z. Y. Liu, et al. 2000. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192:129.
12. Marsters, S. A., M. Yan, R. M. Pitti, P. E. Haas, V. M. Dixit, and A. Ashkenazi. 2000. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10:785.
13. Xia, X. Z., J. Treanor, G. Senaldi, S. D. Khare, T. Boone, M. Kelley, L. E. Theill, A. Colombero, I. Solovyev, F. Lee, et al. 2000. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J. Exp. Med. 192:137.
14. Yan, M., S. A. Marsters, I. S. Grewal, H. Wang, A. Ashkenazi, and V. M. Dixit. 2000. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat. Immunol. 1:37.
15. Thompson, J. S., S. A. Bixler, F. Qian, K. Vora, M. L. Scott, T. G. Cachero, C. Hession, P. Schneider, I. D. Sizing, C. Mullen, et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108.
16. Kanakaraj, P., T. S. Migone, B. Nardelli, S. Ullrich, Y. Li, H. S. Olsen, T. W. Salcedo, T. Kaufman, E. Cochrane, Y. Gan, et al. 2001. BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-κB and ELF-1. Cytokine 13:25.
17. Khare, S. D., and H. Hsu. 2001. The role of TALL-1 and APRIL in immune regulation. Trends Immunol. 22:61.
18. Siegel, R. M., and M. J. Lenardo. 2001. To B or not to B: TNF family signaling in lymphocytes. Nat. Immunol. 2:577.
19. Laabi, Y., A. Egle, and A. Strasser. 2001. TNF cytokine family: more BAFF-ling complexities. Curr. Biol. 11:R1013.
20. Pound, J. 2001. A key role for BAFF in maintaining peripheral B cells. Trends Immunol. 22:659.
21. Do, R. K., and S. Chen-Kiang. 2002. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 13:19.
22. Mackay, F., and C. R. Mackay. 2002. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 23:113.
23. Rolink, A. G., and F. Melchers. 2002. BAFF led B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 14:266.
24. Mackay, F., and J. L. Browning. 2002. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2:465.
25. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453.
26. Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111.
27. Gross, J. A., S. R. Dillon, S. Mudri, J. Johnston, A. Littau, R. Roque, M. Rixon, O. Schou, K. P. Foley, H. Haugen, et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease impaired B cell maturation in mice lacking BLyS. Immunity 15:289.
28. Harless, S. M., V. M. Lentz, A. P. Sah, B. L. Hsu, K. Clise-Dwyer, D. M. Hilbert, C. E. Hayes, and M. P. Cancro. 2001. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 11:1986.
29. Macky, F., S. A. Woodcock, A. C. Lawton, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manisfestations. J. Exp. Med. 190:1697.
30. Khare, S. D., I. Sarosi, X. Z. Xia, S. McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, G. Van, et al. 2000. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97:3370.
31. Wang, H., S. A. Marsters, T. Baker, B. Chan, W. P. Lee, L. Fu, D. Tumas, M. Yan, V. M. Dixit, A. Ashkenazi, and I. S. Grewal. 2001. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2:63263.
32. Xu. S., and K. P. Lam. 2001. B-cell maturation protein, which binds the tumornecrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell. Biol. 21:4067.
33. von Buelow, G. U., J. M. van Deursen, and R. J. Bram. 2001. Regulation of the T-independent humoral response by TACI. Immunity 14:573.
34. Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I. S. Grewal, and V. M. Dixit. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:638.
35. Hatzoglou, A., J. Roussel, M. F. Bourgeade, E. Rogier, C. Madry, J. Inoue, O. Devergne, and A. Tsapis. 2000. TNF receptor family member BCMA (B cell matuation) associates with TNF receptor-associated factor (TRAF) 1, TRAF 2, and TRAF3 and activates NF-κB, Elk-1, c-jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165:1322.
36. von Bulow, G. U., and R. J. Gram. 1997. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278:138.
37. Hsu, H., H. B. Shu, M. G. Pan, and D. V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299.
38. Chen, D., X. Li, Z. Zhai, and H. B. Shu., 2002. A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-κB activation. J. Biol. Chem. 277:15985.
39. Xu, L. G., W. Min, J. Hu, Z. Zhai, and H. B. Shu. 2002. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukocyte Biol. 72:410.
40. Schmiedeknecht, G., C. Kerkhoff, E. Orso, J. Stohr, C. Aslanidis, G. M. Nagy, R. Knuechel, and G. Schmitz. 1996. Isolation and characterization of a 14.5-kDa trichloroacetic-acid-soluble translational inhibitor protein from human monocytes that is upregulated upon cellular differentiation. Eur. J. Biochem. 242:339.
41. Bradley, J. R., and J. S. Pober. 2001. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20:6482.
42. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487.
43. Wajant, H., F. Henkler, and P. Scheurich. 2001. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13:389.
44. Ye, H., Y. C. Park, M. Kreishman, E. Kieff, and H. Wu. 1999. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4:321.
45. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. Activation of IKKα by a second, evolutionary conserved, NF-κ B signaling pathway. Science 293:1495.
46. Kaisho, T., K. Takeda, T. Tsujimura, T. Kawai, F. Nomura, N. Terada, and S. Akira. 2001. IκB kinase α is essential for mature B cell development and function. J. Exp. Med. 193:417.
47. Grossmann, M., L. A. O'Reilly, R. Gugasyan, A. Strasser, J. M. Adams, and S. Gerondakis. 2000. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19:6351.
48. Moore. K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
49. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890.
50. Cross, J. T., and H. P. Benton. 1999. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflamm. Res. 48:255.
51. Hu, H. M., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069.
52. Sato, T., S. Irie, and J. C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:113.
53. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore, 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267-1494.
54. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMPI engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389.
55. Hostager, B. S., and G. A. Bishop. 1999. Contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J. Immunol. 162:630.
56. Nakano, H., H. Oshima, W. Chung, L. Williams-Abbott, C. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:14661.
57. Force, W. R., A. A. Glass, C. A. Benedict, T. C. Cheung, J. Lama, and C. F. Ware. 2000. Discrete signaling regions in the lymphotoxin-β receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-κB pathways. J. Biol. Chem. 275:11121.
58. Leo, E., K. Welsh, S. Matsuzawa, J. M. Zapata, S. Kitada, R. S. Mitchell, K. R. Ely, and J. C. Reed. 1999. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-κB and Jun N-terminal kinase activation. J. Biol. Chem. 274:22414.
59. Pullen, S. S., T. T. Dang, J. J. Crute, and M. R. Kehry. 1999. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs): binding site specificity and activation of downstream pathways by distinct TRAFs. J. Biol. Chem. 274:14246.
60. Ni, C. Z., K. Welsh, E. Leo, C. K. Chiou, H. Wu, J. C. Reed, and K. R. Ely. 2000. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. USA 97:10395.